Hillevax, Inc. (HLVX) Live Share Price, Invest From India

Hillevax, Inc. Stock Performance

as on September 17, 2025 at 6:59 am IST

Day's High
$2.09
Day's Price Range
$2.11
$2.09
0.96%
Upside
52 Week's Low
52 Week's High
$1.34
52-Week Price Range
$2.17
$2.09
35.89%
Downside
3.83%
Upside

Hillevax, Inc. share price movements today

Previous Close: $2.10
Open: $2.10
Volume: 992.1K
Day's Low - High: $2.09 - $2.11
52 Week Low - High: $1.34 - $2.17

Hillevax, Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Hillevax, Inc. Stock Fundamentals & Key Indicators

Check Hillevax, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Hillevax, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hillevax, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Hillevax, Inc.	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$40.7B	127.78%	131.61	8.45%
Beone Medicines Ltd	NA	$31.6B	NA	111.23	5.37%
Vertex Pharmaceuticals Incorporated	BUY	$114.6B	111.25%	29.42	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$77.9B	60.03%	17.76	31.41%

Analyst Recommendation on Hillevax, Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Hillevax, Inc.. Average target price of $2

Hillevax, Inc. Share Price Target

Get share price movements and forecasts by analysts on Hillevax, Inc..

What analysts predicted

-4.5%DOWNSIDE

Target Price

Current Price

$2.09

Analyzed by

11 Analysts

Target

$2.00

Hillevax, Inc. target price $2, a slight downside of -4.5% compared to current price of $2.09. According to 11 analysts rating.

Hillevax, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	2	-	-	-	-	-	-
Gross Profit	0	0	0	2	0	0	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-26	-27	-31	-36	-46	-40	-25	-33	-6	-5
Net Profit Margin	0.00%	0.00%	0.00%	-1290.50%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Hillevax, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	-	0	-2	-2	-
Operating Income	-	-	-	-	-
EBITDA	-	-	-	-	-
Interest Expense	-	-	-	-	-
Depreciation	-	-	-	-	-
Income Before Tax	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Net Income	-2	-85	-257	-123	-147
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Hillevax, Inc.

Funds	Holdings
Takeda Pharmaceutical Co Ltd	13.41%
TANG CAPITAL MANAGEMENT LLC	9.82%
EcoR1 Capital, LLC	4.83%
Lightspeed Management Co LLC	4.6%
Franklin Resources Inc	3.9%

See all

Insights on Hillevax, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 53.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 206.9%
NEGATIVE IMPACT
Price Dip
In the last 3 years, HLVX stock has moved down by -90.4%

About Hillevax, Inc.

HilleVax, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing vaccines. The Company's programs, HIL-214 and HIL-216, are virus-like particle (VLP) based vaccine candidates in development for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. HIL-214 consists of VLPs which are designed to mimic the structure of norovirus and are co-formulated with an alum adjuvant to enhance immunogenicity and stability of the VLPs in solution. HIL-214 is administered intramuscularly via prefilled syringes and has demonstrated stability at standard refrigeration temperatures of four degrees Celsius for 24 months. The Company has in-licensed HIL-216 from Chengdu Kanghua Biological Products Co., Ltd. (Kangh), a Chinese company. Its license provides world-wide rights to the vaccine outside of the Chinese market. HIL-216 includes six common norovirus genotypes: GI.1, GII.2, GII.3, GII.4, GII.6 and GII.17.

Organisation	Hillevax, Inc.
E-voting on shares	Click here to vote

FAQs

What is Hillevax, Inc. share price today?

Hillevax, Inc. share price today is $2.09 as on September 17, 2025 at 1:29 am IST. Hillevax, Inc. share today touched a day high of $2.11 and a low of $2.09.

What is the 52 week high and 52 week low for Hillevax, Inc. share?

Hillevax, Inc. share touched a 52 week high of $2.17 on July 28, 2025 and a 52 week low of $1.34 on April 4, 2025. Hillevax, Inc. stock price today i.e. September 17, 2025 at 1:29 am IST is trending at $2.09,which is 3.69% down from its 52 week high and 55.97% up from its 52 week low.

How to invest in Hillevax, Inc. Stock (HLVX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Hillevax, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hillevax, Inc. Shares that will get you 0.7177 shares as per Hillevax, Inc. share price of $2.09 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Hillevax, Inc. Stock (HLVX) from India?

Indian investors can start investing in Hillevax, Inc. (HLVX) shares with as little as ₹94.138 or $1 (as of March 26, 2026 at 1:14 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹941.38 in Hillevax, Inc. stock (as per the Rupee-Dollar exchange rate as on March 26, 2026 at 1:14 am IST). Based on Hillevax, Inc. share’s latest price of $2.09 as on September 17, 2025 at 1:29 am IST, you will get 4.7847 shares of Hillevax, Inc.. Learn more about fractional shares .